Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah R Kaye

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a DifferenceDeborah R Kaye, Joseph K Canner, Max Kates, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2026
Improving outcomes of patients with advanced prostate cancer through a better understanding of clinical factors contributing to financial toxicity: a qualitative studyEbunoluwa Olunuga, Jeremy Kurnot, Samantha Zhu, et al.
Health Policy OPEN|February 6, 2026
Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United StatesDeborah R Kaye, Hui-Jie Lee, Daniel J George, et al.
Annals of Surgical Oncology|August 19, 2017
Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer SurgeryDeborah R Kaye, Caroline R Richardson, Zaojun Ye, et al.
The Journal of Urology|June 16, 2010
Partial adrenalectomy: underused first line therapy for small adrenal tumorsDeborah R Kaye, Benjamin B Storey, Karel Pacak, et al.
Journal of Medical Economics|February 29, 2024
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United StatesDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
The Oncologist|March 24, 2018
Costs of Cancer Care Across the Disease ContinuumDeborah R Kaye, Hye Sung Min, Lindsey A Herrel, et al.
Urolithiasis|August 6, 2024
Work absence and productivity loss of patients undergoing a trial of spontaneous passage for ureteral stonesIan Berger, Robert Medairos, Ezra Margolin, et al.
Urology|August 21, 2018
The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive ProgramDeborah R Kaye, Zaojun Ye, Jonathan Li, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United StatesDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a DifferenceDeborah R Kaye, Joseph K Canner, Max Kates, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2026
Improving outcomes of patients with advanced prostate cancer through a better understanding of clinical factors contributing to financial toxicity: a qualitative studyEbunoluwa Olunuga, Jeremy Kurnot, Samantha Zhu, et al.
Health Policy OPEN|February 6, 2026
Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United StatesDeborah R Kaye, Hui-Jie Lee, Daniel J George, et al.
Annals of Surgical Oncology|August 19, 2017
Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer SurgeryDeborah R Kaye, Caroline R Richardson, Zaojun Ye, et al.
The Journal of Urology|June 16, 2010
Partial adrenalectomy: underused first line therapy for small adrenal tumorsDeborah R Kaye, Benjamin B Storey, Karel Pacak, et al.
Journal of Medical Economics|February 29, 2024
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United StatesDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
The Oncologist|March 24, 2018
Costs of Cancer Care Across the Disease ContinuumDeborah R Kaye, Hye Sung Min, Lindsey A Herrel, et al.
Urolithiasis|August 6, 2024
Work absence and productivity loss of patients undergoing a trial of spontaneous passage for ureteral stonesIan Berger, Robert Medairos, Ezra Margolin, et al.
Urology|August 21, 2018
The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive ProgramDeborah R Kaye, Zaojun Ye, Jonathan Li, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United StatesDeborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Pageof 6